PetMed Express(US:PETS) Globenewswire·2025-10-15 21:06Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against PetMed Express, Inc. for possible violations of federal securities laws and unlawful business practices affecting stockholders [1][2]. Investigation Details - The investigation is focused on whether PetMed has engaged in unlawful activities that could impact its stockholders [2]. - Investors who have suffered losses and are long-term stockholders are encouraged to reach out for more information regarding their rights and potential claims [3]. Company Background - Bragar Eagel & Squire, P.C. is a law firm recognized nationally, representing both individual and institutional investors in various types of litigation across state and federal courts [4]. - The firm has offices in New York and California and specializes in commercial, securities, and derivative litigation [4]. Recent Company Events - On June 10, 2025, PetMed announced a delay in releasing its fourth quarter and fiscal year 2025 earnings due to the need for additional time to complete the year-end audit process [6]. - Following this announcement, PetMed's stock price dropped by $0.47 per share, or 11.22%, closing at $3.72 per share on June 11, 2025 [6].